Cara Therapeutics reported 1.91M in Stock for its first fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Stock Change
Acadia Pharmaceuticals ACAD:US $ 7.01M 0.87M
Acelrx Pharmaceuticals ACRX:US $ 1.04M 0.07M
Cara Therapeutics CARA:US 1.91M 677K
Chugai Pharma 4519:JP Y 225480M 16642M
Endo International Ordinary Shares ENDP:US $ 283.83M 0.27M
Halozyme Therapeutics HALO:US $ 47.76M 6.15M
JAZZ PHA JAZZ:US $ 985.45M 87.27M
Johnson & Johnson JNJ:US $ 10990M 603M
Neurocrine Biosciences NBIX:US $ 29M 1.5M
Pacira Pharmaceuticals PCRX:US $ 103.66M 5.11M
Pfizer PFE:US $ 9979M 920M
Revance Therapeutics RVNC:US $ 10.66M 0.5M
Supernus Pharmaceuticals SUPN:US $ 88.8M 2.84M
Teva Pharmaceutical Industries TEVA:US $ 4012M 194M
Vanda Pharmaceuticals VNDA:US 1.29M 265K